Waldenstrom macroglobulinemia is a chronic, slow-growing lymphoproliferative disorder. It usually affects older adults and is primarily found in the bone marrow . Waldenström macroglobulinemia (WM) is a distinct clinicopathologic entity demonstrating lymphoplasmacytic lymphoma (LPL) in the bone. Waldenström macroglobulinemia is often an indolent disorder, and many patients are candidates for observation with careful monitoring.
|Published (Last):||9 August 2006|
|PDF File Size:||14.48 Mb|
|ePub File Size:||1.62 Mb|
|Price:||Free* [*Free Regsitration Required]|
Its etiology is unknown, but several studies suggest a possible causal relationship with autoimmune diseases, exposure to environmental factors and chronic antigenic stimulation, such as infection with the hepatitis C virus HCV.
Apropos of a new case. Paratrabecular infiltration; Centrocytes small cells with “cleaved” nuclei and reduced cytoplasm and centroblasts large cells with round or oval nuclei, vesicular chromatin, and low basophilic cytoplasm. Immunophenotypic analysis of Waldenstrom’s macroglobulinemia.
Immunophenotypic variations may occur. Despite the high incidence of HCV infection in these walxenstrom, a statistically significant association between HCV wakdenstrom and WM has not been found. Diagnosis and management of Waldenstrom macroglobulinemia: B-cell neoplasms with homogeneous cold-reacting antibodies cold agglutinins. WM is a rare disease, with only about 1, cases per year in the United States.
The aim of this paper is to describe in detail the current knowledge on the pathophysiology of WM, main clinical manifestations, diagnosis, prognosis and treatment. Fadil A, Taylor DE. A skeletal survey can help distinguish between Df and multiple myeloma.
It is fundamental to distinguish WM from other disorders that could be clinically confused with this disease. Initial immunoglobulin M ‘flare’ after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia. Flow cytometry may be used to examine markers on the cell surface or inside the lymphocytes.
Waldenström’s macroglobulinemia – a review
It is believed that WM originates in memory B-lymphocytes. Some of these markers are particularly ejfermedad for studying the bone marrow infiltrate in the waldenstromm biopsy through immunohistochemical and other studies for the immunophenotypic characterization of B-lymphocytes by flow cytometry.
Rituximab is an IgG1 anti-CD20 monoclonal antibody. Allogeneic stem cell transplantation can induce durable remissions for heavily pre-treated patients. The WM spectrum of dysplasias differs from other spectrums of plasma cell dyscrasias in that it involves not only aberrant plasma cells but also aberrant lymphoplasmacytoid cells enfermedwd that it involves IgM while other plasma dyscrasias involve other antibody isoforms.
LPL primarily involves the bone marrow, but the disease can reach the lymph nodes, spleen and liver, among other organs. When interpreting the results it is important to consider that some parameters could be altered because the monoclonal IgM may interfere waldenstro several measurements performed in automated analyzers, especially in the evaluation of HDL cholesterol, bilirubin, inorganic phosphate, LDL cholesterol, C-reactive protein, creatinine, glucose, urea, iron and calcium ions.
J Dtsch Dermatol Ges. Biologic activity of cold-reacting autoantibodies first of two parts. The clinical application of monoclonal antibodies in chronic lymphocytic leukemia. The deposition of amyloid A protein AA amyloidosis has been documented, although rare, 3738 and may occur in the kidneys and intestines, causing nephrotic syndrome and intestinal malabsorption.
LPL may eventually evolve into a more aggressive form of lymphoma such as as diffuse large B-cell waldenstron.
Useful in patients with Raynaud’s syndrome, acrocyanosis or limb ulceration. Lymphocytes are small or medium in size with irregular nucleus.
This page was last edited on 20 Decemberat Other lymphoproliferative diseases, including marginal zone B-cell lymphoma, chronic lymphocytic waldenstrok and mantle cell lymphoma should be excluded.
Activated mast cells secrete growth and survival factors for B-lymphocytes such as CD40L and APRIL proliferation-inducing ligand15 which may contribute to lymphoplasmocytoid differentiation of malignant cells in the bone marrow.
The enfermedae of this system in symptomatic patients that are candidates for treatment enables tailoring treatment to the patient, taking into account the estimated average survival. Although isotype switching is rarely seen in WM, according to some studies it is possible that it occurs ex vivo and in vivo. Extranodal lymphoplasmacytoid lymphoma immunocytoma presenting as small intestinal obstruction.
Waldenström’s macroglobulinemia – Wikipedia
Cancer Management and Research. Retrieved 29 January Subsequent treatment should be started quickly, as the concentration of IgM will return to its initial level after 4 to 5 weeks.
In patients with peripheral neuropathy, such as progressive symmetrical numbness of the limbs, burning sensation and tingling, pain in the feet and hands. For diagnosis, a bone marrow biopsy is crucial to assess the extent of neoplastic infiltration, the infiltration pattern and cellular morphology. International Journal of Laboratory Hematology. Cold agglutinin-mediated autoimmune hemolytic anemia in Waldenstrom’s macroglobulinemia.
Recently, autologous bone marrow transplantation has been added to the available treatment options. Renal failure is not very common; however, monoclonal IgM may accumulate in the renal glomeruliforming subendothelial deposits that clog glomerular capillaries. Diagnosis and management of Waldenstrom’s macroglobulinemia.
The large size of the monoclonal IgM molecule and waldenstron high concentration contribute to increased blood viscosity and vascular resistance, compromising the blood flow to oxygenate tissues. An overview of its clinical, biochemical, immunological and therapeutic features and our series of patients collected efermedad a single center. Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom’s macroglobulinemia.
Increased levels of bone formation and angiogenesis factors are reduced after successful pefloxacin treatment. Evidence of anemia, constitutional symptoms, hyperviscosity, swollen ed nodesor enlargement of the liver and spleen that re be attributed to an underlying lymphoproliferative disorder.
In fact, the choice of treatment is waldenstdom critical option and should not be taken so as to limit future options, walsenstrom all patients will inevitably present relapses after initial treatment, requiring treatment.
IgM monoclonal gammopathy that excludes chronic lymphocytic leukemia and Mantle cell lymphoma. There is no single accepted treatment for WM. The concentration of sCD27 and assessment of the amount of monoclonal free light chains have been presented as potential biomarkers for laboratory monitoring of therapy. Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events.